Can a woman with Factor V Leiden take progestin-only (progestin) birth control pills?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 13, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Progestin-Only Birth Control Pills for Women with Factor V Leiden

Women with Factor V Leiden can safely use progestin-only birth control pills as they do not increase the risk of venous thromboembolism. 1, 2

Safety Profile of Progestin-Only Pills in Thrombophilia

Progestin-only contraceptives are a safer alternative for women with thrombophilia compared to estrogen-containing methods:

  • Studies show that venous thromboembolism (VTE) risk in women using progestin-only pills is not increased, with a relative risk of 0.90 (95% CI 0.57-1.45) 1
  • The American College of Rheumatology strongly recommends progestin-only pills for women with thrombophilic conditions 1
  • Progestin-only methods are widely accepted as lower-risk options for patients with contraindications to estrogen who still need effective contraception 1

Contraceptive Options for Women with Factor V Leiden

For women with Factor V Leiden, contraceptive options can be prioritized as follows:

  1. First-line options (highest safety profile):

    • Levonorgestrel IUD (relative risk for VTE: 0.61) 1, 2
    • Copper IUD (no hormones, no VTE risk) 1, 2
    • Progestin-only pills 1, 2
  2. Contraindicated options (avoid completely):

    • Any estrogen-containing contraceptives (combined oral contraceptives, patches, rings) 1, 2, 3

Important Considerations

  • Effectiveness: Progestin-only pills have a perfect use failure rate of 0.5% in the first year, but are less effective than IUDs or implants 2
  • Timing requirements: Must be taken at the same time each day, within a 3-hour window 2
  • Pregnancy risk: The risk of pregnancy-related VTE in the general population is >10 times that seen with estrogen-progestin contraceptive use, making effective contraception important 1

Cautions and Monitoring

  • Avoid depot medroxyprogesterone acetate (DMPA) injections as limited data suggest a higher VTE risk (RR 2.67) compared to other progestin-only methods 1
  • While one case report described a pulmonary embolism in a Factor V Leiden carrier using a progestin IUD 4, this is inconsistent with larger studies showing no increased risk 1, 2
  • The absolute risk of VTE in Factor V Leiden carriers using progestin-only methods remains very low compared to estrogen-containing methods 3

Clinical Decision Algorithm

  1. Confirm Factor V Leiden status
  2. Discuss contraceptive options, emphasizing:
    • Complete avoidance of estrogen-containing methods
    • Preference for IUDs (levonorgestrel or copper) due to higher effectiveness
    • Progestin-only pills as an acceptable alternative if IUDs are not desired
  3. If choosing progestin-only pills:
    • Emphasize strict adherence to timing requirements
    • Consider backup contraception method (condoms) for additional protection

The evidence strongly supports that progestin-only pills are a safe contraceptive option for women with Factor V Leiden, though IUDs may offer better effectiveness with similar or better safety profiles.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Contraception with Progestin-Only Pills

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Isolated pulmonary embolism in a patient with progestin intrauterine device and factor V Leiden.

Journal of community hospital internal medicine perspectives, 2019

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.